Trade Summary

Yesterday, Mainolfi Nello, serving as CEO at Kymera Therapeutics, Inc. (KYMR), sold 30,000 shares at $78.06 per share, for a total transaction value of $2,341,939.00. Following this transaction, Mainolfi Nello now holds 663,077 shares of KYMR.

This sale represents a 4.00% decrease in Mainolfi Nello's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Wednesday, December 31, 2025 and publicly disclosed via SEC Form 4 filing on Wednesday, December 31, 2025, meaning the disclosure happened on the same day as the trade.

Kymera Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.